Answers are grounded in this paper and cite their sources.
Well-defined protected glycopolymer poly(2-(2,3,4,6-tetra-O-acetyl-β-D-glucosyloxy)ethyl methacrylate) (PAcGlcEMA) is synthesized by reversible addition–fragmentation chain transfer (RAFT) radical polymerization. In the presence of ethanolamine and 2,2′-dithiodipyridine, PAcGlcEMA-PDS with end thiol-reactive pyridyldisulfide (PDS) group is generated by a one-pot approach. After deprotection of PAcGlcEMA, tripeptide reduced glutathione (GSH) is conjugated to PGlcEMA-PDS by thiol–disulfide exchange reaction under mild conditions. Fluorescent assay and TEM studies demonstrate that the pendant glucose residues on PGlcEMA have specific recognition with protein Concanavalin A (Con A). In comparison to PGlcEMA-PDS, the bioconjugation of GSH to PGlcEMA enhances the affinity of glycopolymer to Con A. The association constant (Ka) for the interaction of PGlcEMA-GSH bioconjugate and Con A is 6.1 × 103 M−1, displaying a high glycoside cluster effect. The disulfide-linked GSH bioconjugate PGlcEMA-GSH shows antioxidant activity. The radical scavenging activity is validated in vitro by 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay. It is found that the scavenging activity is dependent on reaction time and temperature. A sustained radical scavenging activity is observed at 37 °C, and about 50% DPPH radical is cleared after 24 h incubation. The recognition and the antioxidant activity make the peptide–glycopolymer bioconjugate PGlcEMA-GSH have potential for biodetection, biomimetics and targeted antioxidant delivery.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: